FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1977796523> ?p ?o ?g. }

• W1977796523 endingPage "328" @default.
• W1977796523 startingPage "317" @default.
• W1977796523 abstract "Sixty-four patients with symptomatic otomycosis (80 infected ears) confirmed by direct microscopy and culture were randomly treated for I week with ciclopiroxolamine cream 11% (group A, 20 infected ears, 17 patients), ciclopiroxolamine solution 1% (group B, 20 infected ears, 17 patients) and boric acid (group C, 40 infected ears, 30 patients) and daily mechanical suction aspiration of the debris. An attempt was made to match 11 clinical parameters with both the mycological and bacteriological findings. There was no significant association between the fungal species cultured and the clinical parameters did not vary with the presence or absence of different bacteria; pus was never present in fungal otitis externa (Fisher's test, P < 0.001). Before therapy, a significant number of ears had completely sterile bacterial cultures (p < 0.01, chi2 test); saprophytic Gram-positive bacteria increased after treatment, whilst Gram-negative bacteria, Pseudomonas aeruginosa and Proteus species, decreased after treatment. Clinical total cure rates 3 days after the end of therapy ranged from 50% in group A, 25% in group B to 22.5% in group C. Mycological cure rates were 80% (group A), 95% (group B) and 72.5% (group C). Two weeks after the end of therapy the clinical cure rates were 60% (group A), 65% (group B) and 80% (group C) and the mycological cure rates was 65% for group A and 75% for both group B and C. Eleven patients relapsed with otitis externa: four (20%) in groups A and C and three (15%) in group B. In four cases the infection was due to bacteria and the remaining seven were due to fungi. Six sites relapsed with the same fungal species as that isolated at the start of the study. In this short-term assessment the relapse rate was not significantly associated with predisposing conditions. The tolerance was excellent in group A. Four patients (20%) in group B had mild (two patients) or moderate (two patients) burning and itching with each application. Twelve patients (30%) in group C had severe stinging and five of these patients who had perforated tympanic membranes also experienced pain. In terms of clinical and mycological effectiveness, there were no significant differences between the three treatment groups, although group A (ciclopiroxolamine cream 1%) and B (ciclopiroxolamine solution 1%) both showed significantly better tolerance (Fisher's test, P < 0.05) when compared with boric acid (group C)." @default.
• W1977796523 created "2016-06-24" @default.
• W1977796523 creator A5006461540 @default.
• W1977796523 creator A5014864957 @default.
• W1977796523 creator A5030373099 @default.
• W1977796523 creator A5050970506 @default.
• W1977796523 creator A5065326750 @default.
• W1977796523 date "2002-10-01" @default.
• W1977796523 modified "2023-09-30" @default.
• W1977796523 title "Randomized prospective comparative study: short-term treatment with ciclopiroxolamine (cream and solution) versus boric acid in the treatment of otomycosis" @default.
• W1977796523 cites W1875247164 @default.
• W1977796523 cites W1972186435 @default.
• W1977796523 cites W1985143843 @default.
• W1977796523 cites W1999239651 @default.
• W1977796523 cites W2002546868 @default.
• W1977796523 cites W2018456781 @default.
• W1977796523 cites W2039124161 @default.
• W1977796523 cites W2042454905 @default.
• W1977796523 cites W2042939315 @default.
• W1977796523 cites W2045414872 @default.
• W1977796523 cites W2053130175 @default.
• W1977796523 cites W2066975128 @default.
• W1977796523 cites W2073339396 @default.
• W1977796523 cites W2086325902 @default.
• W1977796523 cites W2096533991 @default.
• W1977796523 cites W2104515982 @default.
• W1977796523 cites W2130297181 @default.
• W1977796523 cites W2155497055 @default.
• W1977796523 cites W2157592561 @default.
• W1977796523 cites W2333856689 @default.
• W1977796523 cites W4232311612 @default.
• W1977796523 cites W4237377149 @default.
• W1977796523 cites W4243780771 @default.
• W1977796523 doi "https://doi.org/10.1046/j.1439-0507.2002.00737.x" @default.
• W1977796523 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12572722" @default.
• W1977796523 hasPublicationYear "2002" @default.
• W1977796523 type Work @default.
• W1977796523 sameAs 1977796523 @default.
• W1977796523 citedByCount "38" @default.
• W1977796523 countsByYear W19777965232012 @default.
• W1977796523 countsByYear W19777965232013 @default.
• W1977796523 countsByYear W19777965232014 @default.
• W1977796523 countsByYear W19777965232015 @default.
• W1977796523 countsByYear W19777965232016 @default.
• W1977796523 countsByYear W19777965232018 @default.
• W1977796523 countsByYear W19777965232019 @default.
• W1977796523 countsByYear W19777965232020 @default.
• W1977796523 countsByYear W19777965232021 @default.
• W1977796523 countsByYear W19777965232022 @default.
• W1977796523 countsByYear W19777965232023 @default.
• W1977796523 crossrefType "journal-article" @default.
• W1977796523 hasAuthorship W1977796523A5006461540 @default.
• W1977796523 hasAuthorship W1977796523A5014864957 @default.
• W1977796523 hasAuthorship W1977796523A5030373099 @default.
• W1977796523 hasAuthorship W1977796523A5050970506 @default.
• W1977796523 hasAuthorship W1977796523A5065326750 @default.
• W1977796523 hasConcept C121332964 @default.
• W1977796523 hasConcept C126322002 @default.
• W1977796523 hasConcept C141071460 @default.
• W1977796523 hasConcept C168563851 @default.
• W1977796523 hasConcept C185544564 @default.
• W1977796523 hasConcept C189539697 @default.
• W1977796523 hasConcept C2776439223 @default.
• W1977796523 hasConcept C2776839515 @default.
• W1977796523 hasConcept C2777637488 @default.
• W1977796523 hasConcept C2777785397 @default.
• W1977796523 hasConcept C2780678043 @default.
• W1977796523 hasConcept C2994123057 @default.
• W1977796523 hasConcept C523546767 @default.
• W1977796523 hasConcept C54355233 @default.
• W1977796523 hasConcept C71924100 @default.
• W1977796523 hasConcept C86803240 @default.
• W1977796523 hasConcept C90924648 @default.
• W1977796523 hasConceptScore W1977796523C121332964 @default.
• W1977796523 hasConceptScore W1977796523C126322002 @default.
• W1977796523 hasConceptScore W1977796523C141071460 @default.
• W1977796523 hasConceptScore W1977796523C168563851 @default.
• W1977796523 hasConceptScore W1977796523C185544564 @default.
• W1977796523 hasConceptScore W1977796523C189539697 @default.
• W1977796523 hasConceptScore W1977796523C2776439223 @default.
• W1977796523 hasConceptScore W1977796523C2776839515 @default.
• W1977796523 hasConceptScore W1977796523C2777637488 @default.
• W1977796523 hasConceptScore W1977796523C2777785397 @default.
• W1977796523 hasConceptScore W1977796523C2780678043 @default.
• W1977796523 hasConceptScore W1977796523C2994123057 @default.
• W1977796523 hasConceptScore W1977796523C523546767 @default.
• W1977796523 hasConceptScore W1977796523C54355233 @default.
• W1977796523 hasConceptScore W1977796523C71924100 @default.
• W1977796523 hasConceptScore W1977796523C86803240 @default.
• W1977796523 hasConceptScore W1977796523C90924648 @default.
• W1977796523 hasIssue "7-8" @default.
• W1977796523 hasLocation W19777965231 @default.
• W1977796523 hasLocation W19777965232 @default.
• W1977796523 hasOpenAccess W1977796523 @default.
• W1977796523 hasPrimaryLocation W19777965231 @default.
• W1977796523 hasRelatedWork W1977796523 @default.
• W1977796523 hasRelatedWork W1979076702 @default.
• W1977796523 hasRelatedWork W2087725030 @default.

• next